Jeremie Calais
UCLA / Jonsson Comprehensive Cancer Center · Clinical Research Director, Ahmanson Translational Theranostics · University of California at Los Angeles
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
17
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
31
PubMed author-name match
Trials
Studies that name Jeremie Calais as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 18:22 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07118176 · Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersJonsson Comprehensive Cancer Center · active not recruiting · Anal Carcinoma, Bladder Carcinoma, Breast Carcinoma · principal investigator
- Ph2NCT06288113 · Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA TrialJonsson Comprehensive Cancer Center · recruiting · Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 · principal investigator
- Ph2NCT06216249 · Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)Jonsson Comprehensive Cancer Center · recruiting · Prostate Carcinoma, Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8 · principal investigator
- Early Ph1NCT05365802 · FAPI PET for Lung FibrosisUniversity of California, Los Angeles · active not recruiting · Interstitial Lung Disease, Idiopathic Interstitial Pneumonias, Drug-Induced Pneumonitis · principal investigator
- Early Ph1NCT05160597 · Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive BiopsyJonsson Comprehensive Cancer Center · active not recruiting · Prostate Carcinoma · principal investigator
- Ph2NCT04928820 · 68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation TherapyJonsson Comprehensive Cancer Center · terminated · Biochemically Recurrent Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Prostate Carcinoma · principal investigator
- Early Ph1NCT04857502 · 99mTc-PSMA-I&S Biodistribution in Patients With Prostate CancerJonsson Comprehensive Cancer Center · recruiting · Prostate Carcinoma, Recurrent Prostate Carcinoma · principal investigator
- Ph3NCT04457245 · Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate CancerJonsson Comprehensive Cancer Center · terminated · Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8, Stage IIA Prostate Cancer AJCC v8 · principal investigator
- Ph1NCT04459273 · Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various CancersJonsson Comprehensive Cancer Center · active not recruiting · Bladder Carcinoma, Cervical Carcinoma, Cholangiocarcinoma · principal investigator
- Early Ph1NCT04457258 · 68Ga-FAPi-46 PET/CT Scan in Imaging Patients With SarcomaJonsson Comprehensive Cancer Center · active not recruiting · Metastatic Sarcoma, Recurrent Sarcoma, Sarcoma · principal investigator
- Ph1NCT04457232 · Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology ValidationJonsson Comprehensive Cancer Center · active not recruiting · Metastatic Malignant Neoplasm in the Prostate Gland, Prostate Carcinoma, Recurrent Prostate Carcinoma · principal investigator
- N/ANCT04348682 · Expanded Access Protocol of 68Ga-PSMA-11 for PET ImagingJonsson Comprehensive Cancer Center · approved for marketing · Prostate Cancer · principal investigator
- Early Ph1NCT04282824 · Impact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate CancerJonsson Comprehensive Cancer Center · completed · Prostate Carcinoma · principal investigator
- Ph1NCT04279561 · Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate CancerJonsson Comprehensive Cancer Center · terminated · Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8 · principal investigator
- Early Ph1NCT04147494 · Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer TissuesJonsson Comprehensive Cancer Center · active not recruiting · Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma · principal investigator
- Ph2NCT04050215 · 68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate CancerJonsson Comprehensive Cancer Center · completed · Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Prostate Adenocarcinoma · principal investigator
- Ph3NCT03582774 · Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical ProstatectomyJonsson Comprehensive Cancer Center · active not recruiting · Recurrent Prostate Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 18:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 18:22 UTC. The ranking covers the 200 most relevant of 31 PubMed records, and a shared surname and initials can bring in a namesake. All 31 on PubMed
- Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial.JAMA Oncol · 2019684 citationsRCR 31.4
- 399 citationsRCR 17.6
- 325 citationsRCR 20.6
- 144 citationsRCR 11.2
- 68Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study.J Nucl Med · 2017126 citationsRCR 4.9
- 126 citationsRCR 10.6
- Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study.J Nucl Med · 2020111 citationsRCR 5.4
- Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.J Nucl Med · 2020102 citationsRCR 5.0
- 102 citationsRCR 9.9
- Potential Impact of 68Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer.J Nucl Med · 2018101 citationsRCR 4.1